The twin research registry at SRI international

Twin Research and Human Genetics

Volumn 16, Issue 1, 2013, Pages 463-470

  Krasnow, Ruth E ^a   Jack, Lisa M ^a   Lessov Schlaggar, Christina N ^b   Bergen, Andrew W ^a   Swan, Gary E ^a  

^a SRI INTERNATIONAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

genetics; immunology; metabolism; twins; vaccines

Indexed keywords

INFLUENZA VACCINE; MUTAGENIC AGENT; NICOTINE; OPIATE; VARICELLA ZOSTER VACCINE;

ADVERTIZING; ARTICLE; ENVIRONMENTAL EXPOSURE; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; INFLUENZA VACCINATION; METABOLISM; PAIN; PASSIVE SMOKING; PHENOTYPE; PRIORITY JOURNAL; REGISTER; REGISTRATION; SEASONAL INFLUENZA; TELECONSULTATION; TOBACCO DEPENDENCE; TWIN RESEARCH REGISTRY; TWIN ZYGOSITY; TWINS;

ADULT; CHILD; COHORT STUDIES; DISEASES IN TWINS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; REGISTRIES; RESIDENCE CHARACTERISTICS; SAN FRANCISCO; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84873908630     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1017/thg.2012.81     Document Type: Article

References (55)

1. Al Koudsi, N., Mwenifumbo, J. C., Sellers, E. M., Benowitz, N. L., Swan, G. E., & Tyndale, R. F. (2006). Characterization of the novel CYP2A6, 21 allele using in vivo nicotine kinetics. European Journal of Clinical Pharmacology, 62, 481-484.
2. Angst, M. S., Lazzeroni, L. C., Phillips, N. G., Drover, D. R., Tingle, M., Ray, A.,. Clark, J. D. (2012). Aversive and reinforcing opioid effects: A pharmacogenomic twin study. Anesthesiology, 117, 22-37.
3. Angst,M.S.,Phillips, N. G.,Drover,D. R.,Tingle, M.,Galinkin, J. L., Christians, U.,. Clark, J. D. (2010). Opioid pharmacogenomics using a twin study paradigm: Methods and procedures for determining familial aggregation and heritability. Twin Research and Human Genetics, 13, 412- 425.
4. Angst, M. S., Phillips, N. G., Drover, D. R., Tingle, M., Ray, A., Swan, G. E.,. Clark, J. D. (2012). Pain sensitivity and opioid analgesia: A pharmacogenomic twin study. Pain, 153, 1397-1409.
5. Bell, J. T., & Spector, T. D. (2011). A twin approach to unraveling epigenetics. Trends In Genetics, 27, 116-125.
6. Benowitz, N. L., & Jacob, P. 3rd. (1994). Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clinical Pharmacology and Therapeutics, 56, 483-493.
7. Benowitz, N. L., Lessov-Schlaggar, C. N.,&Swan,G. E. (2008). Genetic influences in the variation in renal clearance of nicotine and cotinine. Clinical Pharmacology and Therapeutics, 84, 243-247.
8. Benowitz, N. L., Lessov-Schlaggar, C. N., Swan, G. E., & Jacob, P. 3rd. (2006). Female sex and oral contraceptive use accelerate nicotine metabolism. Clinical Pharmacology and Therapeutics, 79, 480-488.
9. Benowitz, N. L., Swan, G. E., Jacob, P. 3rd., Lessov-Schlaggar, C. N., & Tyndale, R. F. (2006). CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clinical Pharmacology and Therapeutics, 80, 457-467.
10. Bergen, A. W., Conti, D. V., Van Den Berg, D., Lee, W., Liu, J., Li, D.,. Swan, G. E. (2009). Dopaminergic genes and nicotine dependence in treatment seeking and community smokers. Neuropsychopharmacology, 34, 2252-2264.
11. Bergen, A. W., Javitz, H. S., Michel, M., Krasnow, R., Nishita, D., Lessov-Schlaggar, C. N.,. Swan, G. E. (2010). Metabolic SNPs and nicotine and cotinine metabolism [Abstract]. Annual Meeting of the American Society of Human Genetics. Washington, DC: American Society of Human Genetics.
12. Bergen, A. W., Javitz, H. S., Michel, M., Krasnow, R., Nishita, D., Lessov-Schlaggar, C. N.,. Swan, G. E. (2012). Drug metabolizing enzyme genes and nicotine and cotinine metabolism [Abstract]. Annual Meeting of the American Society of Human Genetics. San Francisco, CA: American Society of Human Genetics.
13. Bergen, A. W., Wacholder, A., Michel, M., Nishita, D., Krasnow, R., Javitz, H. S., & Swan, G. E. (2012). Genomewide association studies on smoking behavior and nicotine dependence [Abstract]. Annual Meeting of the Society for Research on Nicotine and Tobacco. Houston, TX: Society for Research on Nicotine and Tobacco.
14. Carmelli, D., Swan, G. E., DeCarli, C., & Reed, T. (2002). Quantitative genetic modeling of regional brain volumes and cognitive performance in older male twins. Biological Psychology, 61, 139-155.
15. Carmelli, D., Swan, G. E., Robinette, D., & Fabsitz, R. (1992). Genetic influence on smoking: A study of male twins. New England Journal of Medicine, 327, 829-833.
16. Cederlof, R., Friberg, L., Jonsson, E., & Kaij, L. (1961). Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genetica (Basel), 11, 338-362.
17. Conti, D. V., Lee, W., Li, D., Liu, J., Van Den Berg, D., Thomas, P. D.,. Lerman, C., for the Pharmacogenetics of Nicotine Addiction and Treatment Consortium. (2008). Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Human Molecular Genetics, 17, 2834- 2848.
18. Conti, D. V., Lewinger, J. P., Swan, G. E., Tyndale, R. F., Benowitz, N. L., & Thomas, P. D. (2009). Using ontologies in hierarchical modeling of genes and exposure in biologic pathways (Chapter 12). In: Swan,G.E., Baker,T.B.,Chassin, L., Conti, D. V., Lerman, C., Perkins, K. A. (Eds.) National Cancer Institute, Phenotypes and Endophenotypes: Foundations for Genetic Studies of Nicotine Use and Dependence, Tobacco Control Monograph No. 20 (NIH Publication No. 08-6366). Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute.
19. Edwards, A., Civitello, A., Hammond, H. A., & Caskey, C. T. (1991). DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. American Journal ofHuman Genetics, 49, 746-756.
20. Falcone, M., Jepson, C., Benowitz, N., Bergen, A.W., Pinto, A., Wileyto, E. P.,. Ray, R. (2011). Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate amongtreatment-seekingsmokers. Nicotine & Tobacco Research, 13, 498-503.
21. Feinleib, M., Garrison, R. J., Fabsitz, R., Christian, J. C., Hrubec, Z., Borhani, N. O.,. Wagner, J. O. (1977). The NHLBI twin study of cardiovascular disease risk factors: Methodology and summary of results. American Journal of Epidemiology, 106, 284-285.
22. Heath, A. C., Nyholt, D. R., Neuman, R., Madden, P. A., Bucholz, K. K., Todd, R. D.,.Martin, N. G. (2003). Zygosity diagnosis in the absence of genotypic data: An approach using latent class analysis. Twin Research, 6, 22-26.
23. Hrubec, Z., & Neel, J. V. (1978). The National Academy of Sciences - National Research Council Twin Registry: Ten years of operation. Progress in Clinical and Biological Research, 24(Pt B), 153-172.
24. Jacob, P. 3rd., Benowitz, N. L., & Shulgin, A. (1988). Synthesis of optically pure deuterium labeled nicotine, nornicotine and cotinine. Journal of Labelled Compounds and Radiopharmaceuticals, 25, 1117-1128.
25. Jacob, P. 3rd., Wilson, M., Yu, L., Mendelson, J., & Jones, R. T. (2002). Determination of 4-hydroxy-3- methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry. Analytical Chemistry, 7, 5290-5296.
26. Jacob, P. 3rd., Yu, L., Wilson, M., & Benowitz, N. L. (1991). Selected ionmonitoringmethod for determination of nicotine, cotinine and deuterium-labeled analogs: Absence of an isotope effect in the clearance of (S)-nicotine-3',3'- d2 in humans. Biological Mass Spectrometry, 20, 247- 252.
27. Krishnan, E., Lessov-Schlaggar, C. N., Krasnow, R. E., & Swan, G. E. (2012). Nature versus nurture in gout: A twin study. American Journal of Medicine, 125, 499-504.
28. Lee,W., Bergen, A.W., Swan,G. E., Li,D., Liu, J., Thomas, P.,. Conti, D. V. (2011). Gender-stratified gene and genetreatment interactions in smoking cessation. Pharmacogenomics Journal [Aug 2, 2011; Epub ahead of print].
29. Lee,W., Ray, R., Bergen, A. W., Swan, G. E., Thomas, P., Tyndale, R. F.,. Conti, D. V. (2012). DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers. Pharmacogenetics & Genomics, 22, 551-554.
30. Lerman, C., Jepson, C., Wileyto, E. P., Epstein, L. H., Rukstalis, M., Patterson, F.,. Berrettini, W. (2006). Role of functional genetic variation in the dopamine D2 receptor (DRD2)in response to bupropion andnicotine replacement therapy for tobacco dependence:Results of two randomized clinical trials. Neuropsychopharmacology, 31, 231-242.
31. Lessov-Schlaggar, C. N.,Benowitz, N. L., Jacob, P. 3rd.,&Swan, G. E. (2009). Genetic influences on individual differences in nicotine glucuronidation. Twin Research andHuman Genetics, 12, 507-513.
32. Lessov-Schlaggar, C. N., Swan, G. E., DeCarli, C., Krasnow, R. E., Reed, T.,Wolf, P. A.,&Carmelli,D. (2012). Longitudinal genetic analysis of brain volumes in normal elderly males: The NHLBI twin study. Neurobiology of Aging, 33, 636- 644.
33. Lessov-Schlaggar, C. N., Swan, G. E., Reed, T., Wolf, P. A., & Carmelli, D. (2007). Longitudinal genetic analysis of executive function in elderly men. Neurobiology of Aging, 28, 1759-1768.
34. Lin, J., Swan,G.E., Shields, P. G.,Benowitz,N.L., Gu, J., Amos, C. I., de Andrade, M., Spitz, M. R., & Wu, X. (2007). Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: Genotype-phenotype correlation. Cancer Epidemiology Biomarkers and Prevention, 16, 2065-2071.
35. Mwenifumbo, J. C., Lessov-Schlaggar, C. N., Zhou, Q., Krasnow, R. E., Swan, G. E., Benowitz, N. L., & Tyndale, R. F. (2008). Identification of novel CYP2A6, 1B variants: The CYP2A6, 1B allele is associated with faster in vivo nicotine metabolism. Clinical Pharmacology and Therapeutics, 83, 115-121.
36. Pfefferbaum, A., Sullivan, E. V., & Carmelli, D. (2001). Genetic regulation of regional microstructure of the corpus callosum in late life. Neuroreport, 12, 1677-1681.
37. Pickering, G. & Leplege, A. (2011). Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly. Pain Practice, 11, 397-402.
38. Ruau, D., Dudley, J. T., Chen, R., Phillips, N. G., Swan, G. E., Lazzeroni, L. C.,. Angst, M. S. (2012). Integrative approach to pain genetics identifies pain sensitivity loci across diseases. PLoS Computional Biology, 8, e1002538.
39. Runyon, R., Rajeshuni, N., Cachola, L., Swan, G. E., &Nadeau, K. (2012). The effects of smoking on the immune response: Gene methylation and T-cell-based responses in twins discordant for smoking. American Journal of Respiratory Critical Care Medicine, 185, A3878.
40. Sarna, S., Kaprio, J., Sistonen, P., & Koskenvuo, M. (1978). Diagnosis of twin zygosity bymailed questionnaire. Human Heredity, 28, 241-254.
41. Sullivan, E. V., Pfefferbaum, A., Swan, G. E., & Carmelli, D. (2001). Heritability of hippocampal size in elderly twin men: Equivalent influence from genes and environment. Hippocampus, 11, 754-762.
42. Swan, G. E., Benowitz, N. L., Jacob, P. 3rd., Lessov, C. N., Tyndale, R. F., Wilhelmsen, K.,. Wambach, M. (2004). Pharmacogenetics of nicotine metabolism in twins: Methods and procedures. Twin Research, 7, 435- 448.
43. Swan, G. E., Benowitz, N. L., Lessov, C. N., Jacob, P. 3rd., Tyndale, R. F., &Wilhelmsen, K. (2005). Nicotine metabolism: The impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenetics & Genomics, 15, 115-125.
44. Swan, G. E., Carmelli, D., & Cardon, L. R. (1996). The consumption of tobacco, alcohol, and coffee in Caucasian male twins: A multivariate genetic analysis. Journal of Substance Abuse, 8, 19-31.
45. Swan, G. E., Carmelli, D., & Cardon, L. R. (1997). Heavy consumption of alcohol, cigarettes, and coffee in male twins. Journal of Studies in Alcohol, 58, 182-190.
46. Swan, G. E., & Lessov-Schlaggar, C. N. (2009). Tobacco addiction and pharmacogenetics of nicotinemetabolism. Journal of Neurogenetics, 23, 262-271.
47. Swan, G. E., & Carmelli, D. (2002). Evidence for genetic mediation of executive control: A study of aging male twins. Journals of Gerontology Series B Psychological Sciences and Social Sciences, 57, 133-143.
48. Swan, G. E., Javitz, H. S., Jack, L. M., Wessel, J., Michel, M., Hinds, D. A.,. Bergen, A. W. (2011). Varenicline for smoking cessation: Nausea severity and variation in nicotinic receptor genes. Pharmacogenomics Journal, 12, 349- 358.
49. Swan, G. E., Lessov-Schlaggar, C. N., Bergen, A. W., He, Y., Tyndale, R. F., & Benowitz, N. L. (2009). Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine. Pharmacogenetics & Genomics, 19, 388-398.
50. Swan, G. E., McClure, J. B., Jack, L. M., Zbikowski, S. M., Javitz, H. S., Catz, S. L., &McAfee, T. A. (2010). Behavioral counseling and varenicline treatment for smoking cessation. American Journal of PreventiveMedicine, 38, 482-490.
51. Swan, G. E.,Reed, T., Jack, L.M.,Miller, B. L.,Markee, T.,Wolf, P. A.,. Carmelli, D. (1999). Differential genetic influence for components of memory in aging adult twins. Archives of Neurology, 56, 1127-1132.
52. Wessel, J., McDonald, S. M., Hinds, D. A., Stokowski, R. P., Javitz, H. S., Kennemer, M.,. Bergen, A.W. (2010). Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerstrom test fornicotine dependence.Neuropsychopharmacology, 35, 2392-2402.
53. Wu, X., Spitz, M. R., Amos, C. I., Lin, J., Shao, L., Gu, J.,. Swan, G. E. (2006). Mutagen sensitivity has high heritability: Evidence from a twin study. Cancer Research, 66, 5993- 5996.
54. Xing, J., Chen,M.,Wood, C. G., Lin, J., Spitz, M. R.,Ma, J.,. Wu,X. (2008).MitochondrialDNAcontent: Its genetic heritability and association with renal cell carcinoma. Journal of the National Cancer Institute, 100, 1104-1112.
55. Zaitlen, N.,&Kraft, P. (2012).Heritability in the genome-wide association era. Human Genetics, 131, 1655-1664.